Expression of Protein Tyrosine Kinase 6 (PTK6) in Nonsmall Cell Lung Cancer and Their Clinical and Prognostic Significance

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s41283
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Composite Anatomical-Clinical-Molecular Prognostic Model in Nonsmall Cell Lung Cancer

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2010English

Prognostic Significance of RNA-Dependent Protein Kinase on Non-Small Cell Lung Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2010English

Expression of Bone Morphogenetic Protein 6 in Non‑small Cell Lung Cancer and Its Significance

Oncology Letters
Cancer ResearchOncology
2018English

Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Thymidylate Synthase in Situ Protein Expression and Survival in Stage I Nonsmall-Cell Lung Cancer

Cancer
Cancer ResearchOncology
2008English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Receptor Tyrosine Kinase Expression of Circulating Tumor Cells in Small Cell Lung Cancer

Oncoscience
Cancer ResearchOncology
2015English

Expression and Clinical Significance of miR-139-5p in Non-Small Cell Lung Cancer

Journal of International Medical Research
BiochemistryMedicineCell Biology
2019English

TP53 Mutations in Nonsmall Cell Lung Cancer

Journal of Biomedicine and Biotechnology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy